- Home
- MLYS vs FRPH Comparison
MLYS vs FRPH Comparison
Compare MLYS & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- FRPH
- Stock Information
- Founded
- MLYS 2019
- FRPH 1986
- Country
- MLYS United States
- FRPH United States
- Employees
- MLYS N/A
- FRPH N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- MLYS Health Care
- FRPH Finance
- Exchange
- MLYS Nasdaq
- FRPH Nasdaq
- Market Cap
- MLYS 1.0B
- FRPH 537.7M
- IPO Year
- MLYS 2023
- FRPH N/A
- Fundamental
- Price
- MLYS $13.84
- FRPH $27.18
- Analyst Decision
- MLYS Strong Buy
- FRPH
- Analyst Count
- MLYS 4
- FRPH 0
- Target Price
- MLYS $27.00
- FRPH N/A
- AVG Volume (30 Days)
- MLYS 827.2K
- FRPH 52.6K
- Earning Date
- MLYS 08-12-2025
- FRPH 08-06-2025
- Dividend Yield
- MLYS N/A
- FRPH N/A
- EPS Growth
- MLYS N/A
- FRPH 12.32
- EPS
- MLYS N/A
- FRPH 0.36
- Revenue
- MLYS N/A
- FRPH $31,576,000.00
- Revenue This Year
- MLYS N/A
- FRPH N/A
- Revenue Next Year
- MLYS N/A
- FRPH N/A
- P/E Ratio
- MLYS N/A
- FRPH $76.63
- Revenue Growth
- MLYS N/A
- FRPH 4.58
- 52 Week Low
- MLYS $8.24
- FRPH $25.37
- 52 Week High
- MLYS $18.38
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- MLYS 42.26
- FRPH 48.70
- Support Level
- MLYS $12.95
- FRPH $26.73
- Resistance Level
- MLYS $14.09
- FRPH $27.71
- Average True Range (ATR)
- MLYS 0.77
- FRPH 0.61
- MACD
- MLYS -0.14
- FRPH -0.00
- Stochastic Oscillator
- MLYS 28.24
- FRPH 24.41
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).